Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 209.82 | 219.56 |
| 52-Wk Range | 166.30 | 244.99 |
| Last Close | 217.88 |
| Mkt Cap (m) | 128,507.11 |
| Dividend yield | 2.73% |
| ISIN | US0311621009 |
| Volume | 3,868,507 |
| Exchange Venue | NAS |
Company Profile
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Key Information
| Price/Earning | 16.92 |
| Price/Book | 13.28 |
| Price/Sales | 5.68 |
| P/CF | 14.50 |
| Rev Growth (3 year avg) | - |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | - |
| Debt/Equity | - |
Documents
Prospectus
| en 20/02/2020 |
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 20,063 | 21,662 | 22,991 | 22,849 | 23,747 | - |
| Operating Income (m) | 6,191 | 8,470 | 9,794 | 9,973 | 10,263 | - |
| Net Income (m) | 5,158 | 6,939 | 7,722 | 1,979 | 8,394 | - |
| Basic EPS | 6.80 | 9.15 | 10.32 | 2.71 | 12.70 | - |
| Avg. Diluted Shares Outstanding (m) | 770 | 766 | 754 | 735 | 665 | - |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 34,713 | 38,518 | 46,010 | 49,476 | 37,618 | - |
| Non Current Assets (m) | 34,296 | 33,058 | 31,616 | 30,478 | 28,798 | - |
| Total Assets (m) | 69,009 | 71,576 | 77,626 | 79,954 | 66,416 | - |
| Current Liabilities (m) | 7,008 | 8,667 | 11,204 | 9,020 | 13,488 | - |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 25,778 | 28,083 | 29,875 | 25,241 | 12,500 | - |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 8,555 | 9,077 | 10,354 | 11,177 | 11,296 | - |
| Capital Expenditure (m) | -1,003 | -649 | -837 | -664 | -738 | - |
Figures are quoted in USD unless stated otherwise
-7.50 (-3.44%)
$
210.38
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.